Sonnet BioTherapeutics Holdings SONN

Quarterly report 2025-Q2
added 08-13-2025

Sonnet BioTherapeutics Holdings DIO Ratio 2011-2026 | SONN

Annual DIO Ratio Sonnet BioTherapeutics Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	4.35	4.53	5.47	8.44	367	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
367	4.35	77.9

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alnylam Pharmaceuticals ALNY	43.5	$ 330.34	3.6 %	$ 43.3 B	USA
	CollPlant Biotechnologies Ltd. CLGN	130	$ 0.44	-16.64 %	$ 5.04 M	Israel
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Catalyst Pharmaceuticals CPRX	119	$ 24.98	1.17 %	$ 3.05 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Crinetics Pharmaceuticals CRNX	343	$ 37.7	1.26 %	$ 3.55 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aquestive Therapeutics AQST	120	$ 4.09	-0.97 %	$ 437 M	USA
	DBV Technologies S.A. DBVT	332	$ 20.36	-3.32 %	$ 2.84 B	France
	Dyadic International DYAI	161	$ 0.87	-2.8 %	$ 31.5 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain